MoI Launches Third Unified Traffic Awareness Campaign for 2015

Under the Slogan: ‘A Summer without Accidents’

Abu Dhabi, United Arab Emirates - Monday, June 29th 2015 [ME NewsWire]

The Ministry of Interior, represented by the Traffic Coordination Directorate General, launched the third unified traffic awareness campaign for 2015 as per the initiatives within the traffic sector. The campaign is held under the slogan ‘A Summer without Accidents’ and will continue through summer vacation.

The campaign aims to unite all efforts to educate drivers in regards to taking the necessary precautions to ensure that their vehicle is safe and reliable.  Under the campaign, drivers are urged to perform periodic maintenance on their vehicle, to ensure that the tires are safe to drive on, and to abide by the rules and regulations of traffic for their own safety and the safety of others. By following such directives, drivers can help reduce the number of traffic accidents, especially those that occur during the summer.

Brigadier Ghaith Hassan Al Zaabi, Director General of the Traffic Coordination Directorate General at the Ministry of Interior, said that the campaign was launched in order to reach the highest levels of traffic safety for everyone through adjusting road security, enhancing safety, and preventing traffic accidents and run-over incidents.

 “Traffic accidents continue to be a major concern for the public and for the police and security entities in the country alike.  It’s an issue of concern due to the adverse effects that result from the numbers of deaths and injuries, and from the other social impacts that may arise from material damages and expensive property losses,” he said.

Brigadier Al Zaabi explained that the ‘A Summer without Accidents’ campaign comes at the start of the summer vacation, which witnesses an increased number of travelers by land throughout the nation. “It is imperative that drivers conduct a comprehensive examination of their vehicles, and check the necessary vehicle parts -replacing them with new ones, if need be.” He continued by stressing the need for drivers to comply with the maximum height restrictions when loading items to the roof of the vehicle. He urged them not to exceed a height of 60 cm in order to avoid an uneven strain on the vehicle that would make it more difficult to control the car.

In order to preserve the lives of others, he called for the need to increase awareness and to promote a traffic culture for drivers and road users in regards to the importance of ensuring the safety and validity of their vehicles.

He then explained that the campaign to prevent accidents is made possible by the Traffic Coordination Directorate General in the Ministry of Interior in cooperation and coordination with the Traffic and Patrols departments in the UAE and with the private and public sectors concerned with traffic safety.

Brigadier Al Zaabi pointed out that the campaign ‘A Summer without Accidents’ will be addressed through social media sites including Facebook, Twitter, Instagram, online discussion forums, and blogs. “Posters and brochures related to the campaign will be distributed in a number of public centers, gas stations, and public gathering locations. Media seminars will also be held and will host participating officials in campaign events,” he said.

“Driving safely is both an art and a manner of gentility. In light of the increase in the numbers of vehicles, it is imperative that drivers abide by the instructions and guidance to safely travel the long distances and hours by car,” said the Director General, Brigadier Al Zaabi.

In a bid to preserve every road user’s safety, he additionally urged for drivers to: ensure that their passengers buckle up, prevent children below the age of 10 from sitting in the front passenger seats, abide by the designated speed limits, abstain from driving when tired or fatigued, and to not leave the car unattended while the engine is still running.

For more information about:

The Ministry of Interior, please click HERE

Abu Dhabi Police, please click HERE

Follow us and check our Social Media feeds on: YouTube, Facebook and Twitter

The Arabic-language text of this announcement is the official, authoritative version. Translations are provided as an accommodation only, and should be cross-referenced with the Arabic-language text, which is the only version of the text intended to have legal effect.

Contacts

The UAE Minister of Interior's General Secretariat, Tactical Affairs and Security Media Department

Abu Dhabi Police GHQ - Security Media

Chris Cron +971-(0)-50-987-1317

E-mail: cron.media@hotmail.com









Permalink: http://me-newswire.net/news/15025/en

Pershing Square Holdings, Ltd. Releases Monthly Net Asset Value and Performance Report for June 2015

AMSTERDAM. - Saturday, July 4th 2015 [ME NewsWire]

(BUSINESS WIRE)-- Regulatory News:

Pershing Square Holdings, Ltd. (ticker: PSH:NA) today released the following regular monthly Net Asset Value (NAV) and Performance Report for the month of June 2015. The information has also been posted to the PSH website, www.pershingsquareholdings.com. Monthly net asset value and performance are calculated at the close of business on the last business day of the month.

To view the table kindly click here

PAST PERFORMANCE IS NOT NECESSARILY INDICATIVE OF FUTURE RESULTS. All investments involve the possibility of profit and the risk of loss, including the loss of principal. This document does not constitute an offer to sell or the solicitation of an offer to purchase any security or investment product. All information is current as of the date hereof and is subject to change in the future.

(1) Performance results are presented on a net-of-fees basis and reflect the deduction of, among other expenses: management fees, brokerage commissions, administrative fees, and accrued and/or crystallized performance fee, if any. Net performance includes the reinvestment of all dividends, interest, and capital gains. Depending on the timing of a specific investment, net performance for an individual investor may vary from the net performance as stated herein. Performance data and other information contained herein are estimated and unaudited. Net performance is a geometrically linked time weighted calculation.

(2) Includes equity and debt securities and derivatives (including swaps and options) relating to equity and debt securities. In the event that there is a change in market cap category with respect to any non-publicly disclosed position, this information is not updated until such position is publicly disclosed.

(3) Portfolio composition is reflective of the portfolio as of the date of this report, but is not necessarily indicative of the composition of the portfolio in the future which may be significantly different than that shown here.

(4) “Pershing Square Holdings, Ltd. AUM” is the assets under management of Pershing Square Holdings, Ltd. Performance fee crystallized as of the end of the year will be reflected in the following period’s AUM.

(5) “Total Strategy AUM” is the aggregate assets under management of Pershing Square, L.P., Pershing Square International, Ltd., Pershing Square II, L.P. and Pershing Square Holdings, Ltd. Redemptions effective as of the end of any period (including redemptions attributable to crystallized performance fee/allocation, if any) will be reflected in the following period’s AUM.

(6) “Total Firm AUM” is the aggregate of the Total Strategy AUM and the assets under management of PS V, L.P., PS V International, Ltd. and affiliated entities (collectively, “PSV”), less amounts invested in PSV by the entities listed above (as applicable).

Note: Each public share in the Company carries at all times one vote per share. The total voting rights in the Company ("Total Voting Rights") may vary over time given the capital and voting structure of the Company. As of June 30, 2015, Total Voting Rights were 498,715,288. There are 240,128,546 Public Shares, 8,500,796 Management Shares and 5,000,000,000 Class B Shares (held by VoteCo) outstanding (the share classes have 1 vote, 1.0270 votes and 0.0500 votes per share respectively).

Under the Dutch Financial Supervision Act (Wet op het financieel toezicht), anyone who, directly or indirectly, acquires or disposes of shares in the Company and holds voting rights reaching, exceeding or falling below certain thresholds (including 3%, 5% and 10%) of the Total Voting Rights is required to notify the Netherlands Authority for the Financial Markets (Stichting Autoriteit Financële Markten).

In addition, under the Company’s Articles of Incorporation, a person is required to notify the Company of the percentage of the public shares it holds or is deemed to hold (through such person’s direct or indirect holding of financial instruments) if this percentage reaches, exceeds or falls below 3%, 4%, 4.25%, 4.50%, 4.75% or 5% of the total number of outstanding public shares.


As of December 31, 2014, the outstanding Offset Amount to be paid to the investment manager was approximately $102.1M. The “Offset Amount” is an amount equal to the fees and other costs of the placing and admission of the public shares, commissions paid to placement agents and other formation and offering expenses incurred during the private phase of PSH plus accrued interest of 4.25% per annum. As of the date of the placing of the PSH shares, the total Offset Amount was $120M. As of December 31, 2014, the Offset Amount had been reduced by approximately $17.9M net of accrued interest. Once the Offset Amount has been fully paid, PSH’s incentive fee of 16% will be reduced by 20% of the aggregate incentive fees/allocation earned by the investment manager (and its affiliates) on the gains of other private funds managed by the investment manager. Since December 31, 2014, an additional $13.8M net of accrued interest, has been accrued/crystallized towards the Offset Amount. Accrued amounts have not yet been crystallized and are subject to increases/decreases in the future.

About Pershing Square Holdings, Ltd.

Pershing Square Holdings, Ltd. is a concentrated, research-intensive, fundamental value investor in the public markets.

To view the full release including the table, please click here

Contacts

MEDIA

StockWell Communications

Tim Burt, +44 (0)20 7240 2486

Tim.Burt@stockwellgroup.com

 

Quintiles and Quest Diagnostics Launch Q2 Solutions

Closes previously announced clinical trials laboratory services joint venture transaction

RESEARCH TRIANGLE PARK, N.C. & MADISON, N.J. - Friday, July 3rd 2015 [ME NewsWire]

(BUSINESS WIRE)-- Quintiles and Quest Diagnostics today announced the launch of Q2 Solutions, their new combined clinical trials laboratory services organization. Q2 Solutions brings together the clinical trials laboratory operations of the two parent organizations to provide biopharmaceutical customers with the diverse capabilities and end-to-end services required in the rapidly evolving biopharmaceutical industry. Today’s launch of Q2 Solutions is the result of the close of the previously announced global clinical trials laboratory services joint-venture transaction.

Q2 Solutions is strongly positioned as the second-largest central laboratory services company in the world and provides services to customers across all segments of the biopharmaceutical industry – a group that includes all of the top-20 largest biopharmaceutical companies. If Q2 Solutions had been a stand-alone business in 2014, the organization would have generated approximately $575 million in annual revenues.

Quintiles, the world’s largest provider of product development and integrated healthcare services, owns 60% and Quest Diagnostics, the world leader in diagnostic information services, owns 40% of the two separate legal entities that comprise Q2 Solutions.

“Q2 Solutions harnesses the complementary strengths, expertise and scale of two industry leaders,” said Tom Pike, chief executive officer, Quintiles. “This new organization is built upon the strong foundation of its parent companies and provides customers with access to an innovative, progressive and responsive partner with the quality focus, global experience, and deep medical expertise integral to drug development.”

“Clinical laboratory services are central to advances in genomics, precision medicine and drug development. Q2 Solutions is well positioned to generate significant advances in these areas to benefit biopharmaceutical customers and patients,” said Steve Rusckowski, president and chief executive officer, Quest Diagnostics. “This transaction is consistent with Quest’s five-point strategy, because it allows us to maximize the value of our clinical trials assets in a capital-efficient manner while refocusing on our core diagnostic information services business.”

The two parent companies also have entered into a period of exclusive collaboration to explore how to use their data assets to enhance areas such as clinical trial patient recruitment and retention, clinical trial design as well as companion diagnostic development and commercialization.

Q2 Solutions’ experienced management team comprises proven leaders from both Quintiles and Quest Diagnostics. The company’s chief executive officer, Costa Panagos, most recently served as senior vice president and global head of Global Laboratories and Cardiac Safety Services at Quintiles.

“Today is a milestone day for Q2 Solutions as well as the broader biopharmaceutical industry that we serve,” said Panagos. “Q2 Solutions provides customers with industry-leading scientific expertise, a large global laboratory network, and a relentless focus on superior quality delivery to achieve better patient outcomes. These elements are foundational to Q2 Solutions’ promise to help customers improve human health through innovation that transforms science and data into actionable medical insights.”

To learn more about Q2 Solutions, please visit www.Q2LabSolutions.com.

About Quintiles

Quintiles (NYSE: Q) helps biopharma and other healthcare companies improve their probability of success by connecting insights from our deep scientific, therapeutic and analytics expertise with superior delivery for better outcomes. From advisory through operations, Quintiles is the world’s largest provider of product development and integrated healthcare services, including commercial and observational solutions. Conducting operations in approximately 100 countries, Quintiles is a member of the FORTUNE 500 and has been named to FORTUNE’s list of the “World’s Most Admired Companies.” To learn more, visit www.quintiles.com.

About Quest Diagnostics

Quest Diagnostics (NYSE: DGX) empowers people to take action to improve health outcomes. Derived from the world's largest database of clinical lab results, our diagnostic insights reveal new avenues to identify and treat disease, inspire healthy behaviors and improve health care management. Quest annually serves one in three adult Americans and half the physicians and hospitals in the United States, and our 45,000 employees understand that, in the right hands and with the right context, our diagnostic insights can inspire actions that transform lives. Quest Diagnostics is a member of the FORTUNE 500 and is among FORTUNE’s “World’s Most Admired Companies.” www.QuestDiagnostics.com

Forward-Looking Statements

The statements in this press release which are not historical facts, including with respect to the joint venture transaction, may contain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Such forward-looking statements reflect, among other things, current expectations and anticipated results of operations by Quintiles and Quest Diagnostics, all of which are subject to known and unknown risks, uncertainties and other factors that may cause actual results, performance or achievements, market trends, or industry results to differ materially from those expressed or implied by such forward-looking statements. Therefore, readers are cautioned not to place undue reliance on forward-looking statements, which speak only as of the date that they are made. Without limiting the foregoing, the words “anticipates,” “believes,” “estimates,” “expects,” “intends,” “may,” “plans,” “projects,” “should,” “targets,” “will” and the negative thereof and similar words and expressions are intended to identify forward-looking statements. These statements are subject to risks, uncertainties and assumptions, including, but are not limited to, the ability to complete, integrate and achieve the intended objectives with respect to Q2 Solutions, develop new technologies, the competitive environment, lawsuits or private actions, adverse results from pending or future government investigations, attract and retain key employees of the new company; and other factors discussed in the periodic filings with the SEC by Quintiles and Quest Diagnostics, including those described under the section entitled "Risk Factors" in (i) Quintiles’ 2014 Annual Report on Form 10-K, filed with the SEC on February 12, 2015 and (ii) Quest Diagnostics’ 2014 Annual Report on Form 10-K, filed with the SEC on February 24, 2015, as such factors may be updated from time to time in the periodic filings with the SEC by the respective companies, which are accessible on the SEC's website at www.sec.gov. These factors should not be construed as exhaustive and should be read in conjunction with the other cautionary statements that are included in this press release and in the filings by Quintiles and Quest Diagnostics with the SEC. Unless legally required, Quintiles and Quest Diagnostics assume no obligation to update any such forward-looking information to reflect actual results or changes in the factors affecting such forward-looking information.

Click here to subscribe to Mobile Alerts for Quintiles.

Contacts

Quintiles

Phil Bridges, Media Relations (phil.bridges@quintiles.com)

+1.919.998.1653 (office) +1.919.457.6347 (mobile)



Todd Kasper, Investor Relations (InvestorRelations@quintiles.com)

+1.919.998.2590



Quest Diagnostics

Wendy Bost (Media), +1.973.520.2800

Dan Haemmerle (Investors), +1.973.520.2900





Permalink: http://www.me-newswire.net/news/15055/en

New advance in COPD maintenance treatment, Spiolto® Respimat®, approved in first European countries

INGELHEIM, Germany - Thursday, July 2nd 2015 [ME NewsWire]

    Spiolto® Respimat® is built on tiotropium, the active ingredient in Spiriva®, enhanced by olodaterol
    Spiolto® Respimat® provides significant improvements in lung function, COPD symptoms, quality of life and rescue medication use over Spiriva® right from the initial stages when patients need maintenance therapy1
    Spiolto® Respimat® more than doubles lung function* improvement over Spiriva® in patients who had no prior maintenance therapy2,3

(BUSINESS WIRE)-- Boehringer Ingelheim today announced regulatory authority approvals for Spiolto® Respimat® (tiotropium/olodaterol) in first European countries†. Spiolto® Respimat® is a once-daily maintenance treatment to relieve symptoms in adult patients with chronic obstructive pulmonary disease (COPD). Approvals of the treatment in other European countries are expected to follow in the coming months. Spiolto® Respimat® provides significant improvements in lung function, breathlessness, quality of life and rescue medication use over Spiriva® right from the initial stages when patients need maintenance therapy.1 These additional benefits could enable patients to remain active and avoid the downward spiral of COPD for as long as possible.

This Smart News Release features multimedia. View the full release here: http://www.businesswire.com/news/home/20150701006479/en/

COPD is a chronic, progressive, treatable but incurable lung disease that affects 210 million people worldwide4 and is predicted to become the 3rd leading cause of death by 2030.5 Patients are typically diagnosed when lung function is already significantly impaired and maintenance therapy is needed.6 They suffer from symptoms including breathlessness and coughing that often stop them from being active. This can lead to a downward spiral of worsening symptoms and even further inactivity,7 contributing to an increased risk of disability and death.8

“The additional benefits gained from Spiolto® Respimat® compared to Spiriva® are significant for patients and data show the lung function benefits are even greater when used in the initial stages of COPD. It is a promising new therapeutic advance in COPD,” said Roland Buhl, Professor of Medicine and Head of the Pulmonary Department at Mainz University Hospital. “Optimal management right from the start of maintenance therapy may give patients with this highly debilitating lung disease, the best opportunity to stay active, manage their symptoms and have a better quality of life.”

The national regulatory approvals, following finalisation of the decentralised European regulatory procedure on 20th May, are based on data from the >5,000 patient TONADO® 1&2 clinical trials. The TONADO® trials are part of the >15,000 patient TOviTO® clinical trial programme which shows Spiolto® Respimat® provides clinically relevant improvements over Spiriva®ǂ:

    Significant improvement in lung function*, with greatest benefit seen in patients who are at the first stage of needing maintenance therapy for their COPD3 – and more than double the improvement in lung function* in patients who had no prior maintenance therapy§ (148ml vs. 72ml)2
    Reduction in breathlessness and less use of rescue medication among patients1 (22% and 26% improvement in use of daytime and night-time rescue medication over Spiriva® respectively)
    More patients experiencing noticeable improvements in their quality of life (57.5% vs 48.7%)1
    Spiolto® Respimat® was well tolerated with a safety profile that was similar to tiotropium or olodaterol alone1

“Since its first launch in 2002, Spiriva® has brought medical benefits that have made a real difference to the lives of millions of patients with COPD around the world. Spiolto® Respimat® is our newest advance in COPD treatment. Its recent approval in the US**, Canada and Australia, alongside the approval in countries across Europe, is an important step forward in our ongoing commitment to provide effective solutions for patients with COPD,” said Klaus Dugi, Chief Medical Officer, Boehringer Ingelheim. “We anticipate further approvals of Spiolto® Respimat® in other European countries over the coming months.”

Spiolto® Respimat® is built on tiotropium, the active ingredient in Spiriva® - the world’s most prescribed COPD maintenance treatment with over 40 million patient years of real life experience across all COPD severities.9 It is enhanced by olodaterol††, a unique and effective long-acting beta2-agonist with a fast onset of action, specifically designed to complement the efficacy of Spiriva®. Spiolto® is delivered by Respimat®, the only inhaler available that activelyǂǂ delivers a unique mist, meaning the patient just needs to breathe in naturally for the medication to go deep into the lungs.10-16

Intended audiences

This press release is issued from our Corporate Headquarters in Ingelheim, Germany and is intended to provide information about our global business. Please be aware that information relating to the approval status and labels of approved products may vary from country to country, and a country-specific press release on this topic may have been issued in the countries where we do business.

For ‘Notes to Editors’ and ‘References’ please visit: http://www.boehringer-ingelheim.com/news/news_releases/press_releases/2015/02_july_2015_copd.html

* Improvement in trough FEV1 after 24 weeks of treatment

†As of Monday 29th June, Spiolto® Respimat® has been approved in Croatia, United Kingdom, Slovakia, Denmark, Norway, Ireland, Austria, Romania and Spain

ǂ The data in this press release refer to Spiolto® Respimat® 5/5µg dose which is the dose approved by regulatory authorities

§ Patients without prior maintenance therapy at baseline

** Registered as Stiolto™ Respimat® in the US

†† Marketed as Striverdi® Respimat®

ǂǂ Respimat® delivers a metered dose of medication in a mist at the push of a button not requiring the force from the patient’s inhalation

View source version on businesswire.com: http://www.businesswire.com/news/home/20150701006479/en/

Contacts

Boehringer Ingelheim

Corporate Communications

Media + PR

Dr Kristin Jakobs, +49 151 6894 7444

Fax: +49 (6132) 77 6601

press@boehringer-ingelheim.com

or

More information

www.boehringer-ingelheim.com

Hilton Worldwide Applauds Brazilian Government’s Decision to Participate in the U.S. Customs and Border Protection’s “Global Entry” Program

MCLEAN, Va. - Thursday, July 2nd 2015 [ME NewsWire]

(BUSINESS WIRE)-- Hilton Worldwide (NYSE: HLT) applauds the commitment by U.S. President Barack Obama and Brazilian President Dilma Rousseff to incorporate Brazil into the U.S. Customs and Border Protection’s (CBP) Global Entry program. This announcement came following the meeting between the two presidents in Washington where they discussed bilateral cooperation, including expansion of trade and investment between the two countries.

In a joint statement, the Heads of State announced the decision by the Brazilian government to participate in the “Global Entry” program. The Presidents committed to work closely together to meet the requirements of both the United States Visa Waiver Program and Brazil’s applicable legislation to enable American and Brazilian citizens visa-free travel.

The Global Entry program makes it easier for Brazilians to travel to the United States by providing expedited clearance for pre-approved travelers, an important step to the eventual entry of Brazil into the U.S. Visa Waiver Program (VWP) as part of a U.S.-Brazil Trusted Traveler Program. The VWP would further facilitate travel between the U.S. and Brazil by eliminating the need to secure travel visas for temporary visits between the two countries.

“At Hilton Worldwide, we embrace efforts to increase hassle-free, safe travel between countries,” said Christopher J. Nassetta, President and CEO of Hilton Worldwide. “Making it easier for business travelers to travel between the United States and Brazil could lead to record-breaking trade and investment opportunities in both countries, including in the hospitality industry.”

In 2014, over 2.3 million Brazilians visited the U.S., generating $13.1 billion in travel spending and supporting 75,000 American jobs. A U.S.-Brazil Trusted Traveler Program including Global Entry and the VWP has the potential to significantly increase the contribution Brazil, with a population of 200 million, has on the U.S. economy. These measures could also have a sizable economic impact within Brazil, which is seeking additional foreign business and investment as it prepares to host the 2016 Summer Olympics.

About Hilton Worldwide

Hilton Worldwide (NYSE: HLT) is a leading global hospitality company, spanning the lodging sector from luxury and full-service hotels and resorts to extended-stay suites and focused-service hotels. For 95 years, Hilton Worldwide has been dedicated to continuing its tradition of providing exceptional guest experiences. The Company's portfolio of twelve world-class global brands is comprised of more than 4,350 managed, franchised, owned and leased hotels and timeshare properties, with more than 720,000 rooms in 94 countries and territories, including Hilton Hotels & Resorts, Waldorf Astoria Hotels & Resorts, Conrad Hotels & Resorts, Canopy by Hilton, Curio - A Collection by Hilton, DoubleTree by Hilton, Embassy Suites Hotels, Hilton Garden Inn, Hampton Hotels, Homewood Suites by Hilton, Home2 Suites by Hilton and Hilton Grand Vacations. The Company also manages an award-winning customer loyalty program, Hilton HHonors®.

Contacts

Hilton Worldwide

Chris Brooks, 703-883-5808

chris.brooks@hilton.com









Permalink: http://me-newswire.net/news/15047/en

Andersen Global Announces a New Presence in Spain

SAN FRANCISCO. - Wednesday, July 1st 2015 [ME NewsWire]

(BUSINESS WIRE) Andersen Global is proud to announce a new presence in Spain with the addition of Global Abogados, a tax and law firm with offices in Barcelona and Madrid.

“Establishing a presence in Spain furthers our European growth strategy,” said Mark Vorsatz, CEO of Andersen Tax. “Global Abogados is a true fit for our culture and our dedication to providing best-in-class client service. This addition reinforces our commitment to ensuring our clients receive the highest quality tax and legal advice throughout the world.”

Joining Andersen Global in Spain will be approximately 25 professionals including three Partners: Antonio de Weest Prat Jorba, Álvaro Gámez Serracarabassa and Jose María Rebollo Blasco. Global Abogados provides best-in-class tax and legal advice to individuals, families and corporate clients in the areas of international tax, tax compliance and consulting, commercial law, M&A, labor law and bankruptcy.

“With an already robust association in Europe, Andersen Global allows us to better serve the growing international needs of our clients,” said Antonio de Weest Prat Jorba, Office Managing Partner for Global Abogados. “We are looking forward to working with a firm that shares the values we treasured at Arthur Andersen and maintains the same level of commitment to providing quality client service.”

With the addition of two locations in Spain, Andersen Global now has 41 international locations with over 1,100 professionals worldwide. Andersen Global was founded by Andersen Tax in the United States in 2013. Andersen Tax was previously known as WTAS before changing its name in September, 2014 after acquiring the rights to the Andersen name.

Contacts

Andersen Tax

Shereen A. Terrero, 213-593-2307









Permalink: http://me-newswire.net/news/15022/en

GSMA Introduces Additional Programmes for Mobile World Congress Shanghai

Mobile Industry Set to Converge in Shanghai for Largest GSMA Event in Asia

HONG KONG - Wednesday, July 1st 2015 [ME NewsWire]

(BUSINESS WIRE)-- The GSMA today announced the details of new programmes and exhibition features at Mobile World Congress Shanghai, which will be held 15-17 July at the Shanghai New International Expo Centre. The GSMA also announced further exhibitors, sponsors and partners for the Shanghai event.

“With just two weeks until Mobile World Congress Shanghai, we’re gearing up for our largest and most ambitious Asia event ever,” said Michael O’Hara, Chief Marketing Officer, GSMA. “This year’s Congress comprises an even broader range of programmes and events, showcasing the very latest innovations in mobile, and we’re excited to welcome the mobile world to Shanghai in July.”

New Programmes, Partners Confirmed for Shanghai

The GSMA confirmed the addition of several new partner programmes taking place at Mobile World Congress Shanghai. On Wednesday, 15 July, Visa Worldwide is holding its “Visa Ready HCE Summit”, which will bring together leaders in mobile payments to share their knowledge and experience in implementing cloud-based payment solutions. King & Wood Mallesons is also hosting the symposium “Innovate or Perish: Responding to Change in the New Age of Digital Convergence” on Wednesday.

DigiTimes and the GSMA will be co-hosting the Smart Supply-Chain Connectivity Summit on Friday, 17 July, focusing on Asia’s Internet of Things (IoT) supply chain and applications providers. Also on Friday, GlobalPlatform will hold its event, “Standardising the Trusted Execution Environment for Mobile Devices”, which will explore the trusted execution environment and the implications for players across the ecosystem, while C114 will host the “’Internet+’ China Big Data Development Summit”, examining the impact of big data on the communication industry.

The GSMA also announced new partners participating in several events. The GTI Asia Conference, which is hosted by the Global TD-LTE Initiative and China Mobile and supported by the GSMA and the ITU, is focused on accelerating TD-LTE deployment and promoting the convergence of LTE TDD and FDD. Huawei joins the GSMA in presenting the “Entertainment Unlimited Summit”, delving into the confluence of entertainment, the internet and the mobile industry. Additionally, the Smart City Expo World Congress and 2nd Smart Cities India 2016 Expo are the supporting partners for the Smart Cities Summit, which will address the long- and short-term challenges facing governments and municipalities in evolving to a smart city model, as well as the success stories to date.

For more information on Partner Programmes and GSMA Programmes at Mobile World Congress Shanghai, visit www.mwcshanghai.com/learn/.

New on the Exhibition Floor

The Mobile World Congress Shanghai exhibition will showcase the intersection of mobile and eSports with the addition of a live professional video game competition by ESL, the world’s largest eSports company. ESL’s live competitions draw thousands of fans to stadiums around the world and Mobile World Congress Shanghai attendees will now have the opportunity to experience this firsthand. ESL Arena will host Warcraft III group matches, bringing the biggest gaming stars from China and Korea to battle for spots in the semi-finals. Also in the gaming realm, the “Gamelab Mobile Shanghai” mobile games conference and networking event will be presented by HappyUniverse on Friday, 17 July.

Newly confirmed exhibitors for Mobile World Congress Shanghai include Adblock Plus, Cloud Xchange Solutions, Giesecke and Devrient, Oral-B and Net263. Among the new pavilions on the show floor is the European Young Innovators Forum (EYIF) Pavilion in Start-Up Alley. EYIF will bring together young entrepreneurs and innovators from across Europe to share how they are changing the mobile landscape. Also in the exhibition, the Innovation & App Lab presents insightful and inspiring sessions from innovative companies such as Adblock Plus, Brocade, Canonical/Ubuntu, Cina MCommunication Co., MUBIQUO, Qorvo and Teleena, among others. For more information on the exhibition, visit www.mwcshanghai.com/see-do/exhibition/.

Appearing on the Showcase Stage

The Mobile World Congress Shanghai exhibition again includes the Showcase Stage, featuring device demonstrations, product presentations and a series of Showcase Dialogues. MobileMonday Shanghai will hold its fourth MobileMonday China Start-up Challenge, with the winners and runners-up in each category participating in the final round taking place on Wednesday, 15 July on the Showcase Stage. Further Showcase Stage sessions include the China Mobile App Challenge from the Applied Innovation Institute, as well as a Showcase Dialogue with Gene Yu, a former commander in the U.S. Army Special Forces who has become a technology executive and author. For more information, visit www.mwcshanghai.com/see-do/experience/showcase-stage/.

Support for Mobile World Congress Shanghai

China Mobile is the Platinum Event Sponsor for Mobile World Congress Shanghai. CNBC is confirmed as an Official Media Partner, joining Bloomberg Media, C114 China Communication Network, Mobile World Live and the Technology Channel of Tencent Online Media Group. The European Young Innovation Forum (EYIF) has been confirmed as an Association Partner, alongside MobileMonday Shanghai.

Get Involved at Mobile World Congress Shanghai 2015

For more information on the 2015 Mobile World Congress Shanghai, including how to attend, exhibit or sponsor, visit www.mwcshanghai.com. Follow developments and updates on Mobile World Congress Shanghai through our social media channels – follow us on Twitter at @GSMA and use #MWCS15, get regular updates through our LinkedIn Showcase Page at www.linkedin.com/company/mobile-world-congress-shanghai, and follow us on Facebook at www.facebook.com/mwcshanghai. In China, you can follow us on Sina Weibo http://weibo.com/mwcshanghai or on the GSMA account on WeChat.

-ENDS-                                 

About the GSMA

The GSMA represents the interests of mobile operators worldwide, uniting nearly 800 operators with more than 250 companies in the broader mobile ecosystem, including handset and device makers, software companies, equipment providers and Internet companies, as well as organisations in adjacent industry sectors. The GSMA also produces industry-leading events such as Mobile World Congress, Mobile World Congress Shanghai and the Mobile 360 Series conferences.

For more information, please visit the GSMA corporate website at www.gsma.com. Follow the GSMA on Twitter: @GSMA.

Contacts

For the GSMA

Brenda Bu (Beijing)

+8610 8569 9928

bbu@webershandwick.com



or

Vivienne Wu (Beijing)

+8610 8569 2395

vwu3@webershandwick.com



or

Ava Lau (Hong Kong)

+852 2533 9928

alau@webershandwick.com



or

GSMA Press Office

pressoffice@gsma.com



Permalink: http://me-newswire.net/news/15034/en